Data / Form D filings / BioGene Therapeutics Inc.
BioGene Therapeutics Inc.: Form D filings
BioGene Therapeutics Inc., a biotechnology company in Austin, TX, filed 5 Form D notices with the SEC in 2026. The latest, on August 7, 2026, reports $3 million sold of a $3 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5900 BALCONES DR, STE 100, Austin, TX, 78731
- Phone
- 1-512-379-7526
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Texas
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2140719
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | New notice | $3,000,000 | $3,000,000 | 1 | Jun 5, 2026 | sec.gov | |
| Aug 6, 2026 | New notice | $3,000,000 | $3,000,000 | 1 | Mar 10, 2026 | sec.gov | |
| Aug 6, 2026 | New notice | $250,000 | $250,000 | 1 | Aug 19, 2025 | sec.gov | |
| Aug 6, 2026 | New notice | $250,000 | $250,000 | 1 | Aug 18, 2025 | sec.gov | |
| Jul 23, 2026 | New notice | $4,550,000 | $4,550,000 | 6 | Apr 1, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| STEPHEN VAN DEVENTER | Executive Officer, Director | |
| DEEPAK SAMPATH | Director | |
| PATROSKI LAWSON | Director | |
| STEVE GLOVER | Director | |
| RAJ PRUTHI | Director | |
| DAVID TYRONNE HOWTON | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Aug 3, 2026 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BioGene Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.